Chemotherapy Before Liver Resection of Colorectal Metastases

Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first-line advanced colorectal cancer (aCRC): Mature results of the MRC COIN trial.

(2017) T. S. Maughan et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced Liver Injury in Metastatic Colorectal Cancer: Semiquantitative Histologic Analysis of 334 Resected Liver Specimens Shows That Vascular Injury but not Steatohepatitis Is Associated With Preoperative Chemotherapy

(2010) Paul Ryan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Liver Resection Remains a Safe Procedure After Neoadjuvant Chemotherapy Including Bevacizumab

(2010) Dietmar Tamandl et al.   ANNALS OF SURGERY

Predicting High Grade Lesions of Sinusoidal Obstruction Syndrome Related to Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases

(2010) Olivier Soubrane et al.   ANNALS OF SURGERY

Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases

(2010) Diane Goéré et al.   ANNALS OF SURGERY

Recovery of Liver Function After the Cessation of Preoperative Chemotherapy for Colorectal Liver Metastasis

(2010) Takeshi Takamoto et al.   ANNALS OF SURGICAL ONCOLOGY

Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy

(2010) Rebecca C. Auer et al.   CANCER

Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

(2010) Laura Rubbia-Brandt et al.   HISTOPATHOLOGY

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

(2010) Wendy De Roock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury

(2010) Michael J. Overman et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

(2010) Jean-Yves Douillard et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

(2010) Wendy De Roock et al.   LANCET ONCOLOGY

Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases

(2010) Catherine Hubert et al.   SURGERY

Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases

(2009) Anne M. Covey et al.   ANNALS OF SURGERY

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

(2009) Hiroshi Nakano et al.   ANNALS OF SURGERY

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

(2009) Gianluca Masi et al.   ANNALS OF SURGERY

Assessment of Hepatic Steatosis by Expert Pathologists

(2009) Ashraf Mohammad El-Badry et al.   ANNALS OF SURGERY

Response to Neoadjuvant Chemotherapy Does Not Predict Overall Survival for Patients With Synchronous Colorectal Hepatic Metastases

(2009) David J. Gallagher et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab

(2009) Béatrice Aussilhou et al.   ANNALS OF SURGICAL ONCOLOGY

A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases

(2009) Oliver F Bathe et al.   BMC CANCER

Colorectal liver metastasis surgery: analysis of risk factors predicting postoperative complications in relation to the extent of resection

(2009) Ralf Konopke et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients

(2009) Dietmar Tamandl et al.   JOURNAL OF SURGICAL ONCOLOGY

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

(2009) Gunnar Folprecht et al.   LANCET ONCOLOGY

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

(2009) Jolien Tol et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases

(2009) Antoine Brouquet et al.   SURGERY

A meta-analysis of chemotherapy regimen Fluorouracil/Leucovorin/Oxaliplatin Compared with Fluorouracil/Leucovorin in treating advanced colorectal cancer

(2009) Mian Ling Chen et al.   SURGICAL ONCOLOGY-OXFORD

Impact of Preoperative Bevacizumab on Complications After Resection of Colorectal Liver Metastases: Case-Matched Control Study

(2009) Mahfud Mahfud et al.   WORLD JOURNAL OF SURGERY

Clinical Presentation Can Predict Disease Course in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas

(2009) Nir Lubezky et al.   WORLD JOURNAL OF SURGERY

Timing of Multimodality Therapy for Resectable Synchronous Colorectal Liver Metastases: A Retrospective Multi-Institutional Analysis

(2008) Srinevas K. Reddy et al.   ANNALS OF SURGICAL ONCOLOGY

Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases

(2008) Daria Zorzi et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases

(2008) Charles R. Scoggins et al.   ANNALS OF SURGICAL ONCOLOGY

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

(2008) Birgit Gruenberger et al.   BMC CANCER

Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases

(2008) G. Mentha et al.   BRITISH JOURNAL OF SURGERY

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases

(2008) Susan B. Kesmodel et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

(2008) Dan G. Blazer et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer

(2008) Brigit Gruenberger et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

(2008) J. Randolph Hecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

(2008) Carsten Bokemeyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy

(2008) Risa M. Small et al.   JOURNAL OF SURGICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: A large single institution experience

(2008) Giorgio Giraudo et al.   SURGERY

Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases

(2007) G. Morris-Stiff et al.   EJSO

Addition of Bevacizumab to Irinotecan- and Oxaliplatin-Based Preoperative Chemotherapy Regimens Does Not Increase Morbidity after Resection of Colorectal Liver Metastases

(2007) Srinevas K. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS